Health7 months ago
Commission authorizes first treatment for serious chronic lung disease
The Commission has granted EU marketing authorization for ‘brensocatib', a new active substance for the treatment of chronic progressive lung disease (non-cystic fibrosis bronchiectasis, or NCFB)...
